Skip to content

Galderma Group N Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Thu, Mar 4, 2027, after the market closes · estimates and history

Galderma Group N · E.GALD.SW · Switzerland
Use symbol E.GALD.SW in our API & Excel add-in to retrieve this data ↓
189.70
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 32.40%

Galderma Group N Forecast

Galderma Group N short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 32.4% a year, a typical one-standard-deviation range is 181.04–198.36 over a week, 171.96–207.44 over a month and 128.24–251.16 over a year. (Signals as of 1 Nov 2026.)

Galderma Group N Price Chart

MacroFinance.ai

Galderma Group N Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Galderma Group N
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Galderma Group N
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Galderma Group N
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Galderma Group N
P/E
35.83x
Mid-range vs own history
QoQ +10.6%
YoY −54.8%
now 35.832929.27 low88.16 high
ⓘP/E As of 22 Nov 2026.See Galderma Group N returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Galderma Group N
P/S
4.20x
Mid-range vs own history
QoQ +10.6%
YoY −22.5%
now 4.19793.43 low6.02 high
ⓘP/S As of 22 Nov 2026.See Galderma Group N returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Galderma Group N
P/B
5.41x
Stretched vs own history
QoQ +10.6%
YoY +19.0%
now 5.40694.13 low5.5 high
ⓘP/B As of 22 Nov 2026.See Galderma Group N returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Galderma Group N
EV/EBITDA
19.12x
Mid-range vs own history
QoQ +10.1%
YoY −23.6%
now 19.120215.76 low27.63 high
ⓘEV/EBITDA As of 22 Nov 2026.See Galderma Group N returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Galderma Group N
EV/Sales
4.37x
Mid-range vs own history
QoQ +10.1%
YoY −24.5%
now 4.37313.6 low6.39 high
ⓘEV/Sales As of 22 Nov 2026.See Galderma Group N returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Galderma Group N
FCF Yield
4.3%
Mid-range vs own history
QoQ −9.6%
YoY —
now 4.27474.2 low5.23 high
ⓘFCF Yield As of 22 Nov 2026.See Galderma Group N returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Galderma Group N
Earnings Yield
2.8%
Strong vs own history
QoQ −9.6%
YoY +121.4%
now 2.79071.13 low3.42 high
ⓘEarnings Yield As of 22 Nov 2026.See Galderma Group N returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Galderma Group N
Market Cap
$44.5B
Highest in 5 years
QoQ +10.6%
YoY +26.9%
now 44537.690133,655 low45,277 high
ⓘMarket Cap As of 22 Nov 2026.See Galderma Group N returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Galderma Group N
Net Debt
$1.9B
Low vs own history
QoQ 0.0%
YoY −22.2%
now 1859.00251,859 low2,389 high
ⓘNet Debt As of 22 Nov 2026.See Galderma Group N returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Galderma Group N
Net Debt / EBITDA
0.77x
Low vs own history
QoQ 0.0%
YoY −51.9%
now 0.76610.77 low1.59 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Galderma Group N returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Galderma Group N
Current Ratio
1.24x
Strong vs own history
QoQ 0.0%
YoY +13.8%
now 1.24191.09 low1.24 high
ⓘCurrent Ratio As of 22 Nov 2026.See Galderma Group N returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Galderma Group N
Quick Ratio
0.94x
Mid-range vs own history
QoQ 0.0%
YoY +16.5%
now 0.93720.8 low0.94 high
ⓘQuick Ratio As of 22 Nov 2026.See Galderma Group N returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Galderma Group N
Interest Coverage
4.26x
Strong vs own history
QoQ 0.0%
YoY +179.3%
now 4.26271.53 low4.26 high
ⓘInterest Coverage As of 22 Nov 2026.See Galderma Group N returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Galderma Group N
Debt / Equity
0.33x
Low vs own history
QoQ 0.0%
YoY −11.0%
now 0.32780.33 low0.37 high
ⓘDebt / Equity As of 22 Nov 2026.See Galderma Group N returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Galderma Group N
Altman Z-Score
6.98
Strong vs own history
QoQ +7.4%
YoY +27.0%
now 6.98385.45 low7.07 high
ⓘAltman Z-Score As of 22 Nov 2026.See Galderma Group N returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  15 members-only factors: Revenue Growth, Earnings Growth, EBITDA Growth, Estimate Revision 30D and moreSign up
Accounting Red Flags
  17 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Galderma Group N, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Galderma Group N fundamentals: income statement, balance sheet & cash flow

Galderma Group N reported revenue of 5.24bn CHF and net income of 642.2m CHF in FY2025, the year ended 31 December 2025 — revenue up 7.2% and net income up 152.5% on the prior year. Free cash flow was 1.03bn CHF. These figures are as reported in the filings, not restated: 5 fiscal years and 11 quarters of history, back to December 2021.

Revenue (FY2025)
5.24bn CHF
+7.2%
Net income
642.2m CHF
+152.5%
Gross margin
68.86%
Free cash flow
1.03bn CHF
+566.2%
Net debt
1.97bn CHF
Galderma Group N income statement, annual, as reported · CHF millions unless stated
CHF millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue5,241.04,888.84,286.83,883.13,416.2
Cost of revenue1,632.01,492.01,293.81,233.01,033.7
Gross profit3,609.03,396.82,993.02,650.12,382.5
Research & development254.6286.3301.3326.2342.5
Selling, general & admin.—2,400.4—1,970.31,711.0
Operating income829.0710.2536.0353.6329.0
EBITDA1,208.21,026.3851.0633.0524.2
Interest expense158.2349.1589.0408.9350.8
Pre-tax income638.0341.311.0-53.6-79.7
Income tax26.087.068.046.54.5
Net income642.2254.3-56.2-101.7-154.3

Download Galderma Group N fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.GALD.SW&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks the full history, the filing vintages behind each number and API access.
Create free account

Figures in CHF, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Galderma Group N

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Galderma Group N Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Galderma Group N; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How Galderma Group N’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Galderma Group N behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Galderma Group N (Switzerland)

Galderma Group N is a listed security in Switzerland. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Galderma Group N?
Galderma Group N is a listed security in Switzerland. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Galderma Group N price?
The latest close is 189.7 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Galderma Group N in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Galderma Group N?
20-day realised volatility is 32.4% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 9.4% over a month and 4.6% over a week.
What factors affect Galderma Group N?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Galderma Group N, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Galderma Group N?
9 backtested tactical asset allocation strategies trade Galderma Group N through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Galderma Group N returns analysed?
The Statistical Distribution of Returns section shows the distribution of Galderma Group N daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Galderma Group N historical data?
In the Free historical data section of this page: the last 10 years of Galderma Group N daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Galderma Group N historical data (last 10 years)

Browse or instantly download the last 10 years of Galderma Group N daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.GALD.SW&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20182.85
2026-11-19184.7
2026-11-18187.55
2026-11-17187.15
2026-11-16191
2026-11-13191.4
2026-11-12194.4
2026-11-11194.95
2026-11-10188.55
2026-11-09190.65
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.